| Drug NDC: | 43406-0670 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. | |
| Proprietary Name: | Cold/flu Hp |
| Also known as the trade name. It is the name of the product chosen by the labeler. | |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. | |
| Non Proprietary Name: | Arsenictrioxide,baptisiatinctoriaroot,bryoniaalbaroot,solanumdulcamaratop,echinaceaangustifolia,echinaceapurpurea,eupatoriumperfoliatumfloweringtop,ferrosoferricphosphate,gelsemiumsempervirensroot,potassiumchloride,phosphorus,anemonepulsatilla,sulfur,zincacetateanhydrous,zinccarbonate,zinc,zincchloride,zincoxide,zincpicratenonahyrdate,zincvaleratedihydrate,cairinamoschataheart/liverautolysate,influenzinum |
| Also known as the generic name, this is usually the active ingredient(s) of the product. | |
| Labeler Name: | Natural Creations, Inc. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. | |
| Dosage Form: | Liquid |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. | |
| Substance Name: | ANEMONE PULSATILLA - 100 [hp_X]/mL ARSENIC TRIOXIDE - 100 [hp_X]/mL BAPTISIA TINCTORIA ROOT - 100 [hp_X]/mL BRYONIA ALBA ROOT - 100 [hp_X]/mL CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE - 200 [hp_C]/mL ECHINACEA ANGUSTIFOLIA - 100 [hp_X]/mL ECHINACEA PURPUREA - 100 [hp_X]/mL EUPATORIUM PERFOLIATUM FLOWERING TOP - 100 [hp_X]/mL FERROSOFERRIC PHOSPHATE - 100 [hp_X]/mL GELSEMIUM SEMPERVIRENS ROOT - 100 [hp_X]/mL Load more... INFLUENZA A VIRUS A/SINGAPORE/GP1908/2015 IVR-180 (H1N1) WHOLE - 200 [hp_C]/mL PHOSPHORUS - 100 [hp_X]/mL POTASSIUM CHLORIDE - 100 [hp_X]/mL SOLANUM DULCAMARA TOP - 100 [hp_X]/mL SULFUR - 100 [hp_X]/mL ZINC - 100 [hp_X]/mL ZINC ACETATE ANHYDROUS - 100 [hp_X]/mL ZINC CARBONATE - 100 [hp_X]/mL ZINC CHLORIDE - 100 [hp_X]/mL ZINC OXIDE - 100 [hp_X]/mL ZINC PICRATE NONAHYDRATE - 100 [hp_X]/mL ZINC VALERATE DIHYDRATE - 100 [hp_X]/mL |
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. | |
| Route Details: | ORAL |
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. | |
| Marketing Start Date: | 01 Mar, 2018 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. | |
| Marketing End Date: | 15 Jun, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. | |
| Listing Expiration Date: | 31 Dec, 2024 |
| This is the date when the listing record will expire if not updated or certified by the firm. | |
| Manufacturer Name: | Natural Creations, Inc. |
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. | |
| Original Packager: | Yes |
| Whether or not the drug has been repackaged for distribution. | |
| UPC: | 0877730004871 |
| UPC stands for Universal Product Code. | |
| UNII: | I76KB35JEV S7V92P67HO 5EF0HWI5WU T7J046YI2B RN2HC612GY VB06AV5US8 QI7G114Y98 1W0775VX6E 91GQH8I5F7 639KR60Q1Q Load more... FACIFOJ3Z7 27YLU75U4W 660YQ98I10 KPS1B1162N 70FD1KFU70 J41CSQ7QDS H2ZEY72PME EQR32Y7H0M 86Q357L16B SOI2LOH54Z 0057VRD75N MN0RX54EQA |
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. | |
| Pharmacologic Class: | Copper Absorption Inhibitor [EPC] Decreased Copper Ion Absorption [PE] Increased Large Intestinal Motility [PE] Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] Osmotic Activity [MoA] Osmotic Laxative [EPC] Potassium Compounds [CS] Potassium Salt [EPC] |
| These are the reported pharmacological class categories corresponding to the SubstanceNames listed above. | |
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|---|---|---|---|
| 43406-0670-2 | 60 mL in 1 BOTTLE, SPRAY (43406-0670-2) | 01 Mar, 2018 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. | ||||
* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.